Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Mavacamten Capsules

Approval Number

国药准字HJ20240012

CompanyBRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

Registration Date

April 24, 2024

Drug Information

Generic Name

玛伐凯泰胶囊

Trade Name

迈凡妥

Dosage Form

胶囊剂

Strength

2.5mg

Drug Type

化学药品

Registration Date

April 24, 2024

Expiry Date

April 23, 2029

Company Information

Applicant Company

Company NameBRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

Company Address

Level 2/4 Nexus Court, Mulgrave, VIC 3170, Australia

Manufacturing Company

Company NamePatheon Inc

Company Address

2100 Syntex Court, Mississauga, Ontario, L5N 7K9, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

玛伐凯泰胶囊 - NMPA 批准文号 | MedPath